Concordance between the response evaluation criteria in solid tumors version 1.1 and the immune-related response criteria in patients with non-small cell lung cancer treated with nivolumab: a multicenter retrospective cohort study.
Yuki KataokaKatsuya HiranoTomoko NarabayashiSatoshi HaraDaichi FujimotoTae TanakaNoriyuki EbiKeisuke TomiiHiroshige YoshiokaPublished in: Cancer chemotherapy and pharmacology (2017)
We demonstrated a good concordance between the RECIST and the irRC for predicting OS in patients with NSCLC treated with nivolumab.